JPRN-UMIN000000746已完成未知
Phase II study of a combination of TS-1 and TXL for advanced/recurrent gastric cancer patients with peritoneal metastasis - OGSG0401
OGSG0 个研究点目标入组 30 人开始时间: 2007年6月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.with severe cavity fluid which needs drainage 2.with a central nerve symptoms 3.with fresh intestinal beeding 4.with active double cancers 5.with an allergic reaction against TS-1 or TXL 6.with severe allergy against medicine 7.with severe diseases (cardiac failure, arrhythmia, renal dysfunction, liver dysfunction, interstitial pneumonia, severe neural disorder, uncontrolled DM, intestinal obstruction, etc.) 8.under pregnancy or nursing 9.doctors' decision not to register
研究者
相似试验
已完成
2 期
A randomized phase II (/III) study of TXT/TS-1 (DS) combination vs CDDP/5-FU therapy (FUP) in metastatic gastric cancerChemotherapy-naïve metastatic gastric cancerJPRN-C000000104Hiroshima Cancer Therapy Development Organization (HiCTDO)130
招募中
2 期
Phase II study of TS-1+CPT-11+BV followed by TS-1+L-OHP+BV in unresectable advanced colorectal cancer with RAS mutatioColorectal cancerJPRN-UMIN000014892iigata Colorectal Cancer Study Group50
已完成
2 期
Phase II Study of TS-1 with Patient-Reported Outcome(PRO) Evaluation in Elderly Patients with Advanced NSCLCon-small cell lung cancerJPRN-UMIN000002035Department of Respiratory Medicine & Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School40
已完成
2 期
Phase II study of TS-1 for patients with advanced non-small cell lung cancer treated with prior chemotherapy.on-small cell lung cancerJPRN-UMIN000000817agasaki Thoracic Oncology Group32
未知
1 期
Phase1study of a combination of CPT-11 and TS-1 and bevacizumab in patients with metastatic colon cancermetastatic colorectal cancerJPRN-UMIN000001219Department of Surgery, Suita Municipal Hospital24